Binary and Ternary Inclusion Complexes of Niflumic Acid: Synthesis, Characterization, and Dissolution Profile.

2-hydroxypropyl-β-cyclodextrin complexation efficiency dissolution profile drug delivery inclusion complex niflumic acid solubility

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
09 Sep 2024
Historique:
received: 15 08 2024
revised: 01 09 2024
accepted: 04 09 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

Although niflumic acid (NA) is one of the most used non-steroidal anti-inflammatory drugs, it suffers from poor solubility, low bioavailability, and significant adverse effects. To address these limitations, the complexation of NA with cyclodextrins (CDs) is a promising strategy. However, complexing CDs with low molecular weight drugs like NA can lead to low CE. This study explores the development of inclusion complexes of NA with 2-hydroxypropyl-β-cyclodextrin (2HP-β-CD), including the effect of converting NA to its sodium salt (NAs) and adding hydroxypropyl methylcellulose (HPMC) on complex formation. Inclusion complexes were prepared using co-evaporation solvent and freeze-drying methods, and their CE and Ks were determined through a phase solubility study. The complexes were characterized using physicochemical analyses, including FT-IR, DSC, SEM, XRD, DLS, UV-Vis,

Identifiants

pubmed: 39339226
pii: pharmaceutics16091190
doi: 10.3390/pharmaceutics16091190
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : UEFISCDI
ID : PN-III-P4-ID-PCE-2020-2687
Organisme : UEFISCDI
ID : PNIII-P4-ID-PCE-1523

Auteurs

Zohra Bouchekhou (Z)

Chemical Engineering Laboratory, Process Engineering Department, Faculty of Technology, University of Blida 1, Road of Soumaa, BP 270, Blida 09000, Algeria.

Amel Hadj Ziane-Zafour (A)

Chemical Engineering Laboratory, Process Engineering Department, Faculty of Technology, University of Blida 1, Road of Soumaa, BP 270, Blida 09000, Algeria.

Florentina Geanina Lupascu (FG)

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy of Iași, 16 Universitaty Street, 700115 Iași, Romania.

Bianca-Ștefania Profire (BȘ)

Department of Internal Medicine, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy of Iasi, 16 University Street, 700115 Iași, Romania.

Alina Nicolescu (A)

"Petru Poni" Institute of Macromolecular Chemistry, 41A Grigore Ghica-Voda Alley, 700487 Iasi, Romania.

Denisse-Iulia Bostiog (DI)

"Petru Poni" Institute of Macromolecular Chemistry, 41A Grigore Ghica-Voda Alley, 700487 Iasi, Romania.

Florica Doroftei (F)

"Petru Poni" Institute of Macromolecular Chemistry, 41A Grigore Ghica-Voda Alley, 700487 Iasi, Romania.

Ioan-Andrei Dascalu (IA)

"Petru Poni" Institute of Macromolecular Chemistry, 41A Grigore Ghica-Voda Alley, 700487 Iasi, Romania.

Cristian-Dragoș Varganici (CD)

"Petru Poni" Institute of Macromolecular Chemistry, 41A Grigore Ghica-Voda Alley, 700487 Iasi, Romania.

Mariana Pinteala (M)

"Petru Poni" Institute of Macromolecular Chemistry, 41A Grigore Ghica-Voda Alley, 700487 Iasi, Romania.

Lenuta Profire (L)

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy of Iași, 16 Universitaty Street, 700115 Iași, Romania.

Tudor Pinteala (T)

Department of Orthopedics and Traumatology, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy of Iasi, 16 University Street, 700115 Iași, Romania.

Bachir Bouzid (B)

Chemical Engineering Laboratory, Process Engineering Department, Faculty of Technology, University of Blida 1, Road of Soumaa, BP 270, Blida 09000, Algeria.

Classifications MeSH